Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies
- PMID: 18591134
- DOI: 10.1016/s1353-8020(99)00031-0
Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies
Abstract
Parkinson's disease is neuropathologically defined by the presence of intracytoplasmic Lewy bodies and Lewy neurites. Similar filamentous inclusions are also present in dementia with Lewy bodies, a common late-life dementia, which is clinically similar to Alzheimer's disease. Lewy bodies and Lewy neurites are made of abnormal filamentous material containing alpha-synuclein. Glial cytoplasmic inclusions in multiple system atrophy also contain alpha-synuclein. Using recombinant alpha-synuclein, we have produced synthetic filaments indistinguishable from those present in the intracellular inclusions of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Taken together, these findings indicate that Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies.
Similar articles
-
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.Ann N Y Acad Sci. 2000;920:16-27. doi: 10.1111/j.1749-6632.2000.tb06900.x. Ann N Y Acad Sci. 2000. PMID: 11193145 Review.
-
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.Neurosci Lett. 1998 Jul 31;251(3):205-8. doi: 10.1016/s0304-3940(98)00504-7. Neurosci Lett. 1998. PMID: 9726379
-
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Lancet Neurol. 2011. PMID: 21317042
-
Parkinson's disease and other alpha-synucleinopathies.Clin Chem Lab Med. 2001 Apr;39(4):308-12. doi: 10.1515/CCLM.2001.047. Clin Chem Lab Med. 2001. PMID: 11388653 Review.
-
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73. doi: 10.1073/pnas.95.11.6469. Proc Natl Acad Sci U S A. 1998. PMID: 9600990 Free PMC article.
Cited by
-
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.Glia. 2014 Feb;62(2):317-37. doi: 10.1002/glia.22610. Epub 2013 Dec 6. Glia. 2014. PMID: 24310907 Free PMC article.
-
ELISA method to detect α-synuclein oligomers in cell and animal models.PLoS One. 2018 Apr 26;13(4):e0196056. doi: 10.1371/journal.pone.0196056. eCollection 2018. PLoS One. 2018. PMID: 29698510 Free PMC article.
-
The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.Hum Mol Genet. 2014 Sep 15;23(18):4814-21. doi: 10.1093/hmg/ddu196. Epub 2014 Apr 28. Hum Mol Genet. 2014. PMID: 24777780 Free PMC article.
-
Up-regulation of SNCA gene expression: implications to synucleinopathies.Neurogenetics. 2016 Jul;17(3):145-57. doi: 10.1007/s10048-016-0478-0. Epub 2016 Mar 7. Neurogenetics. 2016. PMID: 26948950 Free PMC article. Review.
-
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37305556 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources